IL10 and breast carcinoma: Other studies have shown that IDO in breast cancer mediates MDSC-induced T cell proliferation and Th1 polarization inhibition, promotes T cell apoptosis and the secretion of immunosuppressive cytokines (IL-10 and TGF-β), causing breast cancer immune escape (147).